李红蓉, 吴以岭. 络病研究的传承与创新[J]. 南京中医药大学学报, 2022, 38(12): 1075-1085. DOI: 10.14148/j.issn.1672-0482.2022.1075
引用本文: 李红蓉, 吴以岭. 络病研究的传承与创新[J]. 南京中医药大学学报, 2022, 38(12): 1075-1085. DOI: 10.14148/j.issn.1672-0482.2022.1075
LI Hong-rong, WU Yi-ling. Inheritance and Innovation of Luobing Research[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(12): 1075-1085. DOI: 10.14148/j.issn.1672-0482.2022.1075
Citation: LI Hong-rong, WU Yi-ling. Inheritance and Innovation of Luobing Research[J]. Journal of Nanjing University of traditional Chinese Medicine, 2022, 38(12): 1075-1085. DOI: 10.14148/j.issn.1672-0482.2022.1075

络病研究的传承与创新

Inheritance and Innovation of Luobing Research

  • 摘要: 传承精华,守正创新是新时代中医药事业和产业高质量发展的根本遵循。以“络病证治”为总纲,以“脉络学说”“气络学说”为两翼的中医络病理论体系就是传承了历代医家关于络病的学术思想、理论观点、临证经验并结合现代科学技术系统构建的创新理论,开辟了临床重大疾病防治的新途径。以络病理论为指导,以现代基础研究和临床研究为基石,将临床有效组方转化为系列中药创新药物,在病毒类呼吸系统传染病、微血管病变、神经-内分泌-免疫系统疾病防治及抗衰老方面取得了重大突破。

     

    Abstract: Inheriting essence and keeping integrity and innovation are the fundamental principles for the high-quality development of TCM and its industry in the new era. The theoretical system of Luobing of TCM, with the general outline of " diagnosis and treatment principle of Luobing " and the two wings of "Mailuo theory" and "Qiluo theory", inherits the academic thoughts, theoretical views and clinical experience of successive doctors on Luobing and combines with modern science and technology to construct an innovative theory systematically, which has opened up a new way for the prevention and treatment of major clinical diseases. Guided by the Luobing theory and based on modern basic and clinical research, the clinical effective prescriptions have been transformed into a series of innovative traditional Chinese medicine drugs, and major breakthroughs have been made in the prevention and treatment of viral respiratory infectious diseases, microangiopathy and neuro-endocrine-immune system diseases and anti-aging.

     

/

返回文章
返回